Lack of galectin-3 involvement in murine intestinal nematode and schistosome infection

Parasite Immunology

Volumn 29, Issue 2, 2007, Pages 93-100

  Bickle, Q ^a   Helmby, H ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Galectin; Helminth; Th2

Indexed keywords

ANTIBODY; CYTOKINE; GALECTIN 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; GRANULOMA; IMMUNE RESPONSE; KNOCKOUT MOUSE; MALE; MOUSE; NEMATODIASIS; NONHUMAN; PARASITE VIRULENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; TH2 CELL; TRICHURIS; WILD TYPE;

ANIMALS; ANTIBODIES, HELMINTH; GALECTIN 3; GRANULOMA; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; TH2 CELLS; TRICHURIASIS; TRICHURIS;

MURINAE; MUS; SCHISTOSOMA; SCHISTOSOMA MANSONI; TRICHURIS MURIS; VERMES;

EID: 33846298002     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2006.00923.x     Document Type: Article

References (37)

1. Bethony J, Brooker S, Albonico M, et al. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet 2006; 367: 1521-1532.
2. Pearce EJ & MacDonald AS. The immunobiology of schistosomiasis. Nat Rev Immunol 2002; 2: 499-511.
3. Maizels RM, Balic A, Gomez-Escobar N, Nair M, Taylor MD & Allen JE. Helminth parasites - masters of regulation. Immunol Rev 2004; 201: 89-116.
4. Wynn TA, Thompson RW, Cheever AW & Mentink-Kane MM. Immunopathogenesis of schistosomiasis. Immunol Rev 2004; 201: 156-167.
5. Dell A, Haslam SM, Morris HR & Khoo KH. Immunogenic glycoconjugates implicated in parasitic nematode diseases. Biochim Biophys Acta 1999; 1455: 353-362.
6. Hokke CH & Yazdanbakhsh M. Schistosome glycans and innate immunity. Parasite Immunol 2005; 27: 257-264.
7. Houston KM & Harnett W. Structure and synthesis of nematode phosphorylcholine-containing glycoconjugates. Parasitology 2004; 129: 655-661.
8. Eberl M, Langermans JA, Vervenne RA, et al. Antibodies to glycans dominate the host response to schistosome larvae and eggs: is their role protective or subversive? J Infect Dis 2001; 183: 1238-1247.
9. Naus CW, van Remoortere A, Ouma JH, et al. Specific antibody responses to three schistosome-related carbohydrate structures in recently exposed immigrants and established residents in an area of Schistosoma mansoni endemicity. Infect Immun 2003; 71: 5676-5681.
10. van den Berg TK, Honing H, Franke N, et al. LacdiNAc-glycans constitute a parasite pattern for galectin-3-mediated immune recognition. J Immunol 2004; 173: 1902-1907.
11. Rabinovich GA, Baum LG, Tinari N, et al. Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? Trends Immunol 2002; 23: 313-320.
12. Truong MJ, Gruart V, Liu FT, Prin L, Capron A & Capron M. IgE-binding molecules (Mac-2/epsilon BP) expressed by human eosinophils. Implication in IgE-dependent eosinophil cytotoxicity. Eur J Immunol 1993; 12: 3230-3235.
13. Frigeri LG, Zuberi RI & Liu FT. Epsilon BP, a beta-galactoside- binding animal lectin, recognizes IgE receptor (Fc epsilon RI) and activates mast cells. Biochemistry 1993; 32: 7644-7649.
14. Yamaoka A, Kuwabara I, Frigeri LG & Liu FT. A human lectin, galectin-3 (epsilon bp/Mac-2), stimulates superoxide production by neutrophils. J Immunol 1995; 154: 3479-3487.
15. Liu FT, Hsu DK, Zuberi RI, Kuwabara I, Chi EY & Henderson WRJ. Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages. Am J Pathol 1995; 147: 1016-1028.
16. Hsu DK, Yang RY, Pan Z, Yu L, Salomon DR, Fung-Leung WP & Liu FT. Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am J Pathol 2000; 156: 1073-1083.
17. del Pozo V, Rojo M, Rubio ML, et al. Gene therapy with galectin-3 inhibits bronchial obstruction and inflammation in antigen-challenged rats through interleukin-5 gene downregulation. Am J Respir Crit Care Med 2002; 166: 732-737.
18. Zuberi RI, Hsu DK, Kalayci O, et al. Critical role for galectin-3 in airway inflammation and bronchial hyperresponsiveness in a murine model of asthma. Am J Pathol 2004; 165: 2045-2053.
19. Else KJ, Hultner L & Grencis RK. Modulation of cytokine production and response phenotypes in murine trichuriasis. Parasite Immunol 1992; 14: 441-449.
20. Else KJ, Finkelmann FD, Maliszewski CR & Grencis RK. Cytokine mediated regulation of intestinal helminth infection. J Exp Med 1994; 179: 347-351.
21. Faulkner H, Renauld J-C, Van Snick J & Grencis RK. Interleukin-9 enhances resistance to the intestinal nematode Trichuris muris. Infect Immun 1998; 66: 3832-3840.
22. Helmby H, Takeda K, Akira S & Grencis RK. Interleukin (IL)-18 promotes the development of chronic gastrointestinal helminth infection by downregulating IL-13. J Exp Med 2001; 194: 355-364.
23. Grzych JM, Pearce EJ, Cheever A, et al. Egg disposition is the major stimulus for the production of Th2 cytokines in murine schistosomiasis mansoni. J Immunol 1991; 146: 1322-1327.
24. Okano M, Satoskar AR, Nishizaki K, Abe M & Harn DA. Induction of Th2 responses and IgE is largely due to carbohydrates functioning as adjuvants on Schistosoma mansoni egg antigens. J Immunol 1999; 163: 6712-6717.
25. Faveeuw C, Mallevaey T, Paschinger K, et al. Schistosome N-glycans containing core alpha 3-fucose and core beta 2-xylose epitopes are strong inducers of Th2 responses in mice. Eur J Immunol 2003; 33: 1271-1281.
26. Doenhoff M, Bickle Q, Long E, Bain J & McGregor A. Factors affecting the acquisition of resistance against Schistosoma mansoni in the mouse. I. Demonstration of resistance to reinfection using a model system that involves perfusion of mice within three weeks of challenge. J Helminthol 1978; 52: 173-186.
27. Bancroft AJ & Grencis RK. Th1 and Th2 cells and immunity to intestinal helminths. Chem Immunol 1998; 71: 192-208.
28. Joo HG, Goedegebuure PS, Sadanaga N, Nagoshi M, von Bernstorff W & Eberlein TJ. Expression and function of galectin-3, a beta-galactoside-binding protein in activated T lymphocytes. J Leukoc Biol 2001; 69: 555-564.
29. Cortegano I, del Pozo V, Cardaba B, et al. Galectin-3 downregulates IL-5 gene expression on different cell types. J Immunol 1998; 161: 385-389.
30. Demetriou M, Granovsky M, Quaggin S & Dennis JW. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 2001; 409: 733-739.
31. Acosta-Rodriguez EV, Montes CL, Motran CC, et al. Galectin-3 mediates IL-4-induced survival and differentiation of B cells: functional cross-talk and implications during Trypanosoma cruzi infection. J Immunol 2004; 172: 493-502.
32. Bernardes ES, Silva NM, Ruas LP, et al. Toxoplasma gondii infection reveals a novel regulatory role for galectin-3 in the interface of innate and adaptive immunity. Am J Pathol 2006; 168: 1910-1920.
33. Cliffe LJ & Grencis RK. The Trichuris muris system: a paradigm of resistance and susceptibility to intestinal nematode infection. Adv Parasitol 2004; 57: 255-307.
34. Cliffe LJ, Humphreys NE, Lane TE, Potten CS, Booth C & Grencis RK. Accelerated intestinal epithelial cell turnover: a new mechanism of parasite expulsion. Science 2005; 308: 1463-1465.
35. Nio J, Kon Y & Iwanaga T. Differential cellular expression of galectin family mRNAs in the epithelial cells of the mouse digestive tract. J Histochem Cytochem 2005; 53: 1323-1334.
36. Dudas SP, Yunker CK, Sternberg LR, Byrd JC & Bresalier RS. Expression of human intestinal mucin is modulated by the beta-galactoside binding protein galectin-3 in colon cancer. Gastroenterology 2002; 123: 817-826.
37. Van de Vijver KK, Deelder AM, Jacobs W, Van Marck EA & Hokke CH. LacdiNAc- and LacNAc-containing glycans induce granulomas in an in vivo model for schistosome egg-induced hepatic granuloma formation. Glycobiology 2006; 16: 237-243.